|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fassina A, Cappellesso R and Fassan M:
Classification of non-small cell lung carcinoma in transthoracic
needle specimens using microRNA expression profiling. Chest.
140:1305–1311. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yoo AS, Staahl BT, Chen L and Crabtree GR:
MicroRNA-mediated switching of chromatin-remodelling complexes in
neural development. Nature. 460:642–646. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Madhyastha R, Madhyastha H, Pengjam Y,
Nakajima Y, Omura S and Maruyama M: NFkappaB activation is
essential for miR-21 induction by TGFβ1 in high glucose conditions.
Biochem Biophys Res Commun. 451:615–621. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Han H, Sun D, Li W, Shen H, Zhu Y, Li C,
Chen Y, Lu L, Li W, Zhang J, et al: A c-Myc-MicroRNA functional
feedback loop affects hepatocarcinogenesis. Hepatology.
57:2378–2389. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mueller DW and Bosserhoff AK: MicroRNA
miR-196a controls melanoma-associated genes by regulating HOX-C8
expression. Int J Cancer. 129:1064–1074. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schimanski CC, Frerichs K, Rahman F,
Berger M, Lang H, Galle PR, Moehler M and Gockel I: High miR-196a
levels promote the oncogenic phenotype of colorectal cancer cells.
World J Gastroenterol. 15:2089–2096. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Popovic R, Riesbeck LE, Velu CS, Chaubey
A, Zhang J, Achille NJ, Erfurth FE, Eaton K, Lu J, Grimes HL, et
al: Regulation of mir-196b by MLL and its overexpression by MLL
fusions contributes to immortalization. Blood. 113:3314–3322. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guan Y, Mizoguchi M, Yoshimoto K, Hata N,
Shono T, Suzuki SO, Araki Y, Kuga D, Nakamizo A, Amano T, et al:
miRNA-196 is upregulated in glioblastoma but not in anaplastic
astrocytoma and has prognostic significance. Clin Cancer Res.
16:4289–4297. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Zhang M, Chen H, Dong Z, Ganapathy
V, Thangaraju M and Huang S: Ratio of miR-196s to HOXC8 messenger
RNA correlates with breast cancer cell migration and metastasis.
Cancer Res. 70:7894–7904. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li X, Shi Y, Yin Z, Xue X and Zhou B: An
eight-miRNA signature as a potential biomarker for predicting
survival in lung adenocarcinoma. J Transl Med. 12:1592014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zheng R and Blobel GA: GATA transcription
factors and cancer. Genes Cancer. 1:1178–1188. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Aronson BE, Stapleton KA and Krasinski SD:
Role of GATA factors in development, differentiation, and
homeostasis of the small intestinal epithelium. Am J Physiol
Gastrointest Liver Physiol. 306:G474–G490. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tian F, Li D, Chen J, Liu W, Cai L, Li J,
Jiang P, Liu Z, Zhao X, Guo F, et al: Aberrant expression of GATA
binding protein 6 correlates with poor prognosis and promotes
metastasis in cholangiocarcinoma. Eur J Cancer. 49:1771–1780. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tian F, Chen J, Zheng S, Li D, Zhao X,
Jiang P, Li J and Wang S: miR-124 targets GATA6 to suppress
cholangiocarcinoma cell invasion and metastasis. BMC Cancer.
17:1752017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Haveri H, Westerholm-Ormio M, Lindfors K,
Mäki M, Savilahti E, Andersson LC and Heikinheimo M: Transcription
factors GATA-4 and GATA-6 in normal and neoplastic human
gastrointestinal mucosa. BMC Gastroenterol. 8:92008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Belaguli NS, Aftab M, Rigi M, Zhang M,
Albo D and Berger DH: GATA6 promotes colon cancer cell invasion by
regulating urokinase plasminogen activator gene expression.
Neoplasia. 12:856–865. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheung WK, Zhao M, Liu Z, Stevens LE, Cao
PD, Fang JE, Westbrook TF and Nguyen DX: Control of alveolar
differentiation by the lineage transcription factors GATA6 and HOPX
inhibits lung adenocarcinoma metastasis. Cancer Cell. 23:725–738.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen C, Zhang Y, Zhang L, Weakley SM and
Yao Q: MicroRNA-196: Critical roles and clinical applications in
development and cancer. J Cell Mol Med. 15:14–23. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu YC, Chang JT, Liao CT, Kang CJ, Huang
SF, Chen IH, Huang CC, Huang YC, Chen WH, Tsai CY, et al:
OncomiR-196 promotes an invasive phenotype in oral cancer through
the NME4-JNK-TIMP1-MMP signaling pathway. Mol Cancer. 13:2182014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hamamoto J, Soejima K, Yoda S, Naoki K,
Nakayama S, Satomi R, Terai H, Ikemura S, Sato T, Yasuda H, et al:
Identification of microRNAs differentially expressed between lung
squamous cell carcinoma and lung adenocarcinoma. Mol Med Rep.
8:456–462. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Võsa U, Vooder T, Kolde R, Fischer K, Välk
K, Tõnisson N, Roosipuu R, Vilo J, Metspalu A and Annilo T:
Identification of miR-374a as a prognostic marker for survival in
patients with early-stage nonsmall cell lung cancer. Genes
Chromosomes Cancer. 50:812–822. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen K and Rajewsky N: The evolution of
gene regulation by transcription factors and microRNAs. Nat Rev
Genet. 8:93–103. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fantini S, Salsi V, Reggiani L, Maiorana A
and Zappavigna V: The miR-196b miRNA inhibits the GATA6 intestinal
transcription factor and is upregulated in colon cancer patients.
Oncotarget. 8:4747–4759. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kwei KA, Bashyam MD, Kao J, Ratheesh R,
Reddy EC, Kim YH, Montgomery K, Giacomini CP, Choi Y-L, Chatterjee
S, et al: Genomic profiling identifies GATA6 as a candidate
oncogene amplified in pancreatobiliary cancer. PLoS Genet.
4:e10000812008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zito G, Naselli F, Saieva L, Raimondo S,
Calabrese G, Guzzardo C, Forte S, Rolfo C, Parenti R and Alessandro
R: Retinoic acid affects lung adenocarcinoma growth by inducing
differentiation via GATA6 activation and EGFR and Wnt inhibition.
Sci Rep. 7:47702017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mehta A, Cordero J, Dobersch S,
Romero-Olmedo AJ, Savai R, Bodner J, Chao CM, Fink L, Guzmán-Díaz
E, Singh I, et al: Non-invasive lung cancer diagnosis by detection
of GATA6 and NKX2-1 isoforms in exhaled breath condensate. EMBO Mol
Med. 8:1380–1389. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim JS, Kurie JM and Ahn YH: BMP4
depletion by miR-200 inhibits tumorigenesis and metastasis of lung
adenocarcinoma cells. Mol Cancer. 14:1732015. View Article : Google Scholar : PubMed/NCBI
|
